Clinical Trial Update: Open-label Study of Neuraminidase Inhibitor Treatment in STEMI Patients [Phase 4]

View source ↗

Summary

Open-label Phase 4 trial evaluating a neuraminidase inhibitor in STEMI patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction
• Stemi

Drugs mentioned

• Neuraminidase inhibitor

Snippet

Sponsor: Tongji Hospital | Conditions: ST Elevation Myocardial Infarction, STEMI | Phase 4 | Status: UNKNOWN